Literature DB >> 21914899

Genome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis.

Leonardo H F Gomes1, Thomas D Otto, Erico A Vasconcellos, Patrícia M Ferrão, Renata M Maia, Aline S Moreira, Marcelo A Ferreira, Luiz R R Castello-Branco, Wim M Degrave, Leila Mendonça-Lima.   

Abstract

Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the only vaccine available against tuberculosis, and the strains used worldwide represent a family of daughter strains with distinct genotypic characteristics. Here we report the complete genome sequence of M. bovis BCG Moreau, the strain in continuous use in Brazil for vaccine production since the 1920s.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914899      PMCID: PMC3187452          DOI: 10.1128/JB.05827-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  The in vitro evolution of BCG vaccines.

Authors:  Serge Mostowy; Anthony G Tsolaki; Peter M Small; Marcel A Behr
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

Review 2.  BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis--review.

Authors:  Thereza Christina Benévolo-de-Andrade; Renata Monteiro-Maia; Catherine Cosgrove; Luiz Roberto R Castello-Branco
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-09-15       Impact factor: 2.743

3.  Whole-genome sequences of four Mycobacterium bovis BCG vaccine strains.

Authors:  Yuanlong Pan; Xi Yang; Jia Duan; Na Lu; Andrea S Leung; Vanessa Tran; Yongfei Hu; Na Wu; Di Liu; Zhiming Wang; Xuping Yu; Chen Chen; Yuanyuan Zhang; Kanglin Wan; Jun Liu; Baoli Zhu
Journal:  J Bacteriol       Date:  2011-04-08       Impact factor: 3.490

4.  Consed: a graphical tool for sequence finishing.

Authors:  D Gordon; C Abajian; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

5.  Genome plasticity of BCG and impact on vaccine efficacy.

Authors:  Roland Brosch; Stephen V Gordon; Thierry Garnier; Karin Eiglmeier; Wafa Frigui; Philippe Valenti; Sandrine Dos Santos; Stéphanie Duthoy; Céline Lacroix; Carmen Garcia-Pelayo; Jacqueline K Inwald; Paul Golby; Javier Nuñez Garcia; R Glyn Hewinson; Marcel A Behr; Michael A Quail; Carol Churcher; Bart G Barrell; Julian Parkhill; Stewart T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

6.  Comparative genomics of BCG vaccines by whole-genome DNA microarray.

Authors:  M A Behr; M A Wilson; W P Gill; H Salamon; G K Schoolnik; S Rane; P M Small
Journal:  Science       Date:  1999-05-28       Impact factor: 47.728

Review 7.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Authors:  T Oettinger; M Jørgensen; A Ladefoged; K Hasløv; P Andersen
Journal:  Tuber Lung Dis       Date:  1999

8.  The complete genome sequence of Mycobacterium bovis.

Authors:  Thierry Garnier; Karin Eiglmeier; Jean-Christophe Camus; Nadine Medina; Huma Mansoor; Melinda Pryor; Stephanie Duthoy; Sophie Grondin; Celine Lacroix; Christel Monsempe; Sylvie Simon; Barbara Harris; Rebecca Atkin; Jon Doggett; Rebecca Mayes; Lisa Keating; Paul R Wheeler; Julian Parkhill; Bart G Barrell; Stewart T Cole; Stephen V Gordon; R Glyn Hewinson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.

Authors:  Andrea S Leung; Vanessa Tran; Zuowei Wu; Xuping Yu; David C Alexander; George Fu Gao; Baoli Zhu; Jun Liu
Journal:  BMC Genomics       Date:  2008-09-15       Impact factor: 3.969

View more
  17 in total

1.  Lipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 substrain.

Authors:  Takashi Naka; Shinji Maeda; Mamiko Niki; Naoya Ohara; Saburo Yamamoto; Ikuya Yano; Jun-Ichi Maeyama; Hisashi Ogura; Kazuo Kobayashi; Nagatoshi Fujiwara
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

2.  Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis.

Authors:  Yanely Tirado; Alina Puig; Nadine Alvarez; Reinier Borrero; Alicia Aguilar; Frank Camacho; Fatima Reyes; Sonsire Fernández; José Luis Pérez; Dulce Mata Espinoza; Jorge Alberto Barrios Payán; María Elena Sarmiento; Mohd-Nor Norazmi; Rogelio Hernández-Pando; Armando Acosta
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?

Authors:  Renata Monteiro-Maia; Rosa Teixeira de Pinho
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-09       Impact factor: 2.743

4.  A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

Authors:  Adeliane Castro da Costa; Abadio de Oliveira Costa-Júnior; Fábio Muniz de Oliveira; Sarah Veloso Nogueira; Joseane Damaceno Rosa; Danilo Pires Resende; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.

Authors:  Fernanda Marques de Carvalho; Luciana Silva Rodrigues; Nádia Cristina Duppre; Iris Maria Peixoto Alvim; Marcelo Ribeiro-Alves; Roberta Olmo Pinheiro; Euzenir Nunes Sarno; Maria Cristina Vidal Pessolani; Geraldo Moura Batista Pereira
Journal:  PLoS Negl Trop Dis       Date:  2017-05-03

6.  Gain of function in Mycobacterium bovis BCG Moreau due to loss of a transcriptional repressor.

Authors:  Renata Monteiro-Maia; Paloma Rezende Correa; Periela da Silva Sousa-Vasconcelos; Rosa Teixeira de Pinho; Leila Mendonça-Lima
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-10-11       Impact factor: 2.743

7.  Complete Genome Sequence of Mycobacterium bovis BCG Korea, the Korean Vaccine Strain for Substantial Production.

Authors:  Sun Myung Joung; Sung Joo Jeon; Young Ju Lim; Jong-Sung Lim; Beom-Soon Choi; Ik-Young Choi; Jeong Hee Yu; Kyung-In Na; En-Hi Cho; Sang-Sook Shin; Young Kil Park; Chang-Ki Kim; Hee-Jin Kim; Sung Weon Ryoo
Journal:  Genome Announc       Date:  2013-03-14

8.  First Whole-Genome Sequence of a Clinical Isolate of Multidrug-Resistant Mycobacterium bovis BCG.

Authors:  A Renvoisé; S Pang; C Bernard; F Brossier; N Veziris; E Capton; V Jarlier; W Sougakoff
Journal:  Genome Announc       Date:  2014-07-10

9.  Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms.

Authors:  Lu Zhang; Huan-Wei Ru; Fu-Zeng Chen; Chun-Yan Jin; Rui-Feng Sun; Xiao-Yong Fan; Ming Guo; Jun-Tao Mai; Wen-Xi Xu; Qing-Xia Lin; Jun Liu
Journal:  Mol Ther       Date:  2015-12-08       Impact factor: 11.454

10.  Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia).

Authors:  R Ludannyy; M Alvarez Figueroa; D Levi; M Markelov; V Dedkov; N Aleksandrova; G Shipulin
Journal:  Genome Announc       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.